Gabapentin

Treatment for Shingles

Typical Dosage: 300-3600 mg daily in divided doses

Effectiveness
70%
Safety Score
65%
Clinical Trials
8
Participants
8K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
MethπŸ’€
Cigarettes🚬
Chemo☒️
Alcohol🍺
MorphineπŸ’Š
AntibioticsπŸ’‰
TylenolπŸ’Š
ExerciseπŸƒ
WaterπŸ’§
65
DangerousModerateSafe
Treatment Details
Dosage Range
300-3600 mg daily in divided doses
Time to Effect
Days to weeks for full effect
Treatment Duration
Weeks to months
Evidence Quality
MODERATE
Number Needed to Treat (NNT)
6(Treat 6 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
20(Treat 20 patients to see 1 additional serious adverse event)
Confidence Score
80%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$80
Monitoring:$150
Side Effect Mgmt:$50
Total Annual:$280
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
EXCELLENT
ICER
$30,000/QALY
QALYs Gained
0.2
Outcome-Based Costs
Cost per Responder
$509.09
Gabapentin Outcomes

for Shingles

Efficacy Outcomes
Overall Effectiveness
+70%
Response Rate
+55%
Common Side Effects
Dizziness
+25%
Somnolence
+22%
Peripheral edema
+8%
Ataxia
+7%

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
1 active trial recruiting for Gabapentin in Shingles

Multimodal Nerve Block and Pulse Radiofrequency for Acute Herpes Zoster Pain

NCT06798662NOT YET RECRUITINGNA
View Study
120 participants
INTERVENTIONAL
Baotou, China
Started: Feb 1, 2025
Completed Clinical Trials
5 completed trials for Gabapentin in Shingles

Acupuncture in Herpes Zoster Neuralgia (ACUZoster)

NCT00885586COMPLETEDPHASE4
View Study
68 participants
INTERVENTIONAL
Munich, Germany
Started: Nov 1, 2008

Reduction of Postherpetic Neuralgia in Herpes Zoster

NCT01250561COMPLETEDNA
View Study
133 participants
INTERVENTIONAL
Houston, United States
Started: Feb 1, 2002

Safety and Efficacy of Gabapentin in Postherpetic Neuralgia

NCT00636636COMPLETEDPHASE3
View Study
452 participants
INTERVENTIONAL
Birmingham, United States +38 more
Started: Mar 1, 2008

Phase IV Study of FDA Approved, Once-Daily GRALISEβ„’(Gabapentin) Tablets for the Treatment of Postherpetic Neuralgia

NCT01426230COMPLETED
View Study
201 participants
OBSERVATIONAL
Mobile, United States +36 more
Started: Sep 1, 2011

Ultrasound-Guided Erectro Spinae Plane Block Versus Stellate Ganglion Block for Patients With Upper Limb Acute Herpes Zoster Pain.

NCT06307444COMPLETEDNA
View Study
93 participants
INTERVENTIONAL
Tanta, Egypt
Started: Mar 20, 2024